The role of funding and policies on innovation in cancer drug development
Open Access
- 1 January 2010
- journal article
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 4, 164
Abstract
Ecancermedicalscience is the peer-reviewed open access cancer journal founded by the European Institute of Oncology in Milan. We consider articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epideKeywords
This publication has 104 references indexed in Scilit:
- Has the US Cancer Centre model been ‘successful’? Lessons for the European cancer communityMolecular Oncology, 2009
- ‘Tackling cancer in the EU: The role of innovation’Molecular Oncology, 2008
- Clinical trials for children with cancer in Europe – Still a long way from harmonisation: A report from SIOP EuropeEuropean Journal of Cancer, 2008
- Trends in the global funding and activity of cancer researchMolecular Oncology, 2008
- Rebuilding immunity in cancer patientsBlood Cells, Molecules, and Diseases, 2008
- Europe combating cancer: The European Union's commitment to cancer research in the 6th Framework ProgrammeMolecular Oncology, 2007
- Mapping the emergence and development of translational cancer researchEuropean Journal of Cancer, 2006
- Developing a paradigm of drug innovation: an evaluation algorithmDrug Discovery Today, 2006
- The cervical cancer epidemic that screening has prevented in the UKThe Lancet, 2004
- Priority setting for pharmaceuticalsThe European Journal of Health Economics, 2004